The relationship between anxiety and serum Urotensin-II and S100B levels in patients with essential hypertension; [Esansiyel hipertansiyonlu hastalarda anksiyete ile serum ürotensin-II ve S100B seviyeleri arasındaki ilişki]

Review ArticleAçık Erişim

Özet

Objective: In hypertensive people, some biochemical parameters that are associated with oxidative stress and endothelial functions may play a role in the manifestation of anxiety symptoms, and even in the intensification of clinical symptoms of the disease. The purpose of our correlative study is to examine the association between anxiety severity and levels of oxidative stress parameters of Urotensin-II and S100B protein in patients with essential hypertension. Method: A total of 153 patients, who have applied Sociodemographic and Clinical Data Form, Beck Anxiety Inventory (BAI), Beck Depression Inventory and venous blood samples were taken after blood pressure measurement. S100B and Urotensin-II levels were measured with Enzyme-Linked Immunosorbent Assay method. Results: A positive correlation was determined between depression and anxiety scores, and systolic blood pressure (p=0.049, r= 0.160; p<0.01, r=0.292). There was a positive relation between BAI scores and Urotensin-II levels (p= 0.043, r= 0.164). A positive correlation was determined between Urotensin-II levels and S100B levels (p<0.01, r= 0.711). A statistically significant difference was observed in serum Urotensin-II levels between depression group and no depression group (p=0.017). Discussion: It was determined in our study that Urotensin-II level increased with increasing anxiety level in essential hypertension patients. It was also determined that Urotensin-II level was higher in hypertensive patients with depression compared to patients who don't have depression. Our study will shed light on new studies that will investigate the contribution of Urotensin- II and S100B in the etiology of patients diagnosed with essential hypertension, which is very commonly accompanied by anxiety and depressive symptoms. © 2021 ANP Publishing. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13445Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5505/kpd.2021.67044Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKazğan, Aslı
dc.contributor.authorKorkmaz, Sevda
dc.contributor.authorYildiz, Sevler
dc.contributor.authorKorkmaz, Hasan
dc.contributor.authorTelo, Selda
dc.contributor.authorAtmaca, Murad
dc.date.accessioned2026-10-18T20:28:16.735076021Z
dc.date.available2026-10-18T20:28:16.735076021Z
dc.date.issued2021
dc.description.abstractObjective: In hypertensive people, some biochemical parameters that are associated with oxidative stress and endothelial functions may play a role in the manifestation of anxiety symptoms, and even in the intensification of clinical symptoms of the disease. The purpose of our correlative study is to examine the association between anxiety severity and levels of oxidative stress parameters of Urotensin-II and S100B protein in patients with essential hypertension. Method: A total of 153 patients, who have applied Sociodemographic and Clinical Data Form, Beck Anxiety Inventory (BAI), Beck Depression Inventory and venous blood samples were taken after blood pressure measurement. S100B and Urotensin-II levels were measured with Enzyme-Linked Immunosorbent Assay method. Results: A positive correlation was determined between depression and anxiety scores, and systolic blood pressure (p=0.049, r= 0.160; p<0.01, r=0.292). There was a positive relation between BAI scores and Urotensin-II levels (p= 0.043, r= 0.164). A positive correlation was determined between Urotensin-II levels and S100B levels (p<0.01, r= 0.711). A statistically significant difference was observed in serum Urotensin-II levels between depression group and no depression group (p=0.017). Discussion: It was determined in our study that Urotensin-II level increased with increasing anxiety level in essential hypertension patients. It was also determined that Urotensin-II level was higher in hypertensive patients with depression compared to patients who don't have depression. Our study will shed light on new studies that will investigate the contribution of Urotensin- II and S100B in the etiology of patients diagnosed with essential hypertension, which is very commonly accompanied by anxiety and depressive symptoms. © 2021 ANP Publishing. All rights reserved.
dc.identifier.doi10.5505/kpd.2021.67044
dc.identifier.eissn2146-7153
dc.identifier.endpage323
dc.identifier.issn1302-0099
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85115913824
dc.identifier.startpage315
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13445
dc.identifier.volume24
dc.identifier.wosWOS:000692661900005
dc.language.isoen
dc.publisherANP Publishing
dc.relation.ispartofKlinik Psikiyatri Dergisi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnxiety
dc.subjectEssential hypertension
dc.subjectS100B
dc.subjectUrotensin-II
dc.titleThe relationship between anxiety and serum Urotensin-II and S100B levels in patients with essential hypertension; [Esansiyel hipertansiyonlu hastalarda anksiyete ile serum ürotensin-II ve S100B seviyeleri arasındaki ilişki]
dc.typeReview Article
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.trdizin0
rdl.citation.wos1
rdl.departmentFIRAT ÜNİVERSİTESİ
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentT.C. SAĞLIK BAKANLIĞI
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)